With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Many of them have only been approved for sale in the last few years. The most widely known of GLP-1 drugs, semaglutide is sold under well-known brand names such as Ozempic and Wegovy. According to the ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food and drink makers to cash in. Consumers taking GLP-1 drugs to lose weight ...

Retatrutide — an experimental drug nicknamed “triple G” — could ... the active ingredient in Ozempic and Wegovy. Obese adults who took the weekly injection retatrutide lost up to 22% ...

Ozempic and Lilly’s Zepbound all appeared during subsequent breaks. There was also a commercial for compounded semaglutide by Hers. While jokes about the Golden Globes being sponsored by these weight ...

WASHINGTON — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden ...

The deal gives Novo Nordisk more manufacturing power for its obesity drugs Ozempic and Wegovy. Many other pharma companies want a piece of that pie, Roop said. "Obesity is going to be a $100 ...

Ozempic and its peers, known as GLP-1 drugs, were initially produced to help people manage diabetes, but these drugs have become increasingly popular for medical weight loss. Proponents of these ...